GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » EV-to-EBITDA

Adcock Ingram Holdings (JSE:AIP) EV-to-EBITDA : 7.43 (As of May. 31, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adcock Ingram Holdings's enterprise value is R8,566 Mil. Adcock Ingram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was R1,152 Mil. Therefore, Adcock Ingram Holdings's EV-to-EBITDA for today is 7.43.

The historical rank and industry rank for Adcock Ingram Holdings's EV-to-EBITDA or its related term are showing as below:

JSE:AIP' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.07   Med: 7.81   Max: 14.39
Current: 7.44

During the past 13 years, the highest EV-to-EBITDA of Adcock Ingram Holdings was 14.39. The lowest was 5.07. And the median was 7.81.

JSE:AIP's EV-to-EBITDA is ranked better than
74.69% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.98 vs JSE:AIP: 7.44

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Adcock Ingram Holdings's stock price is R52.30. Adcock Ingram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was R5.014. Therefore, Adcock Ingram Holdings's PE Ratio (TTM) for today is 10.43.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Adcock Ingram Holdings EV-to-EBITDA Historical Data

The historical data trend for Adcock Ingram Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings EV-to-EBITDA Chart

Adcock Ingram Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.29 6.44 5.99 6.04 6.33

Adcock Ingram Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.04 - 6.33 -

Competitive Comparison of Adcock Ingram Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's EV-to-EBITDA falls into.


;
;

Adcock Ingram Holdings EV-to-EBITDA Calculation

Adcock Ingram Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8565.901/1152.174
=7.43

Adcock Ingram Holdings's current Enterprise Value is R8,566 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adcock Ingram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was R1,152 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Adcock Ingram Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.30/5.014
=10.43

Adcock Ingram Holdings's share price for today is R52.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adcock Ingram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was R5.014.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Adcock Ingram Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India.